(19)
(11) EP 4 739 346 A1

(12)

(43) Date of publication:
13.05.2026 Bulletin 2026/20

(21) Application number: 24838696.3

(22) Date of filing: 05.07.2024
(51) International Patent Classification (IPC): 
A61K 45/06(2006.01)
 A61P 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/00; A61K 45/06; A61K 31/519; C07K 2317/31; C07K 16/2803; A61K 39/39541; A61K 2039/505; C07K 2317/92; C07K 2317/76; C07K 2317/33; Y02A 50/30
 
C-Sets:
  1. A61K 31/519, A61K 2300/00;
  2. A61K 39/39541, A61K 2300/00;
(86) International application number:
PCT/CN2024/103749
(87) International publication number:
WO 2025/011443 (16.01.2025 Gazette 2025/03)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 07.07.2023 WO PCT/CN2023/106333

(71) Applicant: D3 Bio(Wuxi) Co., Ltd.
Wuxi, JiangSu, 214092 (CN)

(72) Inventors:
  • CHEN, Zhijian
    Shanghai 200120 (CN)
  • ZHANG, Jing
    Shanghai 200120 (CN)
  • RUI, Haopeng
    Shanghai 200120 (CN)
  • WANG, Tienan
    Shanghai 200120 (CN)
  • YANG, Xiaofeng
    Shanghai 200120 (CN)

(74) Representative: Cabinet Becker et Associés 
25, rue Louis le Grand
75002 Paris
75002 Paris (FR)

   


(54) COMBINATION THERAPIES FOR THE TREATMENT OF CANCER